Literature DB >> 21217409

Relationships among diabetic retinopathy, antioxidants, and glycemic control.

Carly S Y Lam1, Iris F F Benzie, Siu Wai Choi, Lily Y L Chan, Vincent T F Yeung, George C Woo.   

Abstract

PURPOSE: Type 2 Diabetes Mellitus (DM) is increasing worldwide and affects ∼11% of the Hong Kong population. Diabetic retinopathy (DR) is a common cause of vision loss in type 2 DM. Risk of DR is increased by poor glycemic control, elevated lipids, and blood pressure, but it is not possible to predict the development or progression of DR at an individual level. Increased oxidative stress is thought to play a role. The use of a wider biomarker profile incorporating biomarkers of antioxidant status and oxidative stress may aid identification of individuals at higher risk or at very early stages of developing DR.
METHODS: Four hundred twenty type 2 DM subjects without diabetic complications were investigated. Eyes were examined for DR and anterior and posterior ocular segment pathology. DR was graded according to Early Treatment Diabetic Retinopathy Study criteria. Demographic data were collected. Traditional risk factors plus biomarkers of antioxidant status and oxidative stress in fasting blood and urine were determined.
RESULTS: Overall DR prevalence was 89%. No significant differences in any demographic measures or biomarkers were found among those subjects with different DR grades, or in those without DR. Significant correlations (p < 0.0001) between HbA1c and DNA damage, (ρ = 0.32) and fasting plasma glucose and DNA damage (ρ = 0.52) were seen. DNA damage was also significantly and inversely correlated (p < 0.0001) with both plasma ascorbic acid (ρ = -0.41) and plasma total antioxidant level (ρ = -0.21).
CONCLUSIONS: DR prevalence was very high in this group, but no biomarker differences were seen in those with DR compared to those free of DR, or in those with different degrees of severity of DR. This group of 420 subjects is being followed up to investigate whether the extended biomarker profile at baseline is related to progression of and/or incident DR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217409     DOI: 10.1097/OPX.0b013e318208494a

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  7 in total

1.  Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy.

Authors:  Emrullah Beyazyıldız; Ali Bülent Cankaya; Esra Ergan; Mustafa Alparslan Anayol; Yasemin Ozdamar; Sevilay Sezer; Mehmet Hakan Tırhış; Pelin Yılmazbaş; Faruk Oztürk
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease.

Authors:  J V Calderón-Salinas; E G Muñoz-Reyes; J F Guerrero-Romero; M Rodríguez-Morán; R L Bracho-Riquelme; M A Carrera-Gracia; M A Quintanar-Escorza
Journal:  Mol Cell Biochem       Date:  2011-05-28       Impact factor: 3.396

3.  Neurodegeneration in diabetic retina and its potential drug targets.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

4.  Therapeutic Effect of P-Cymene on Lipid Profile, Liver Enzyme, and Akt/Mtor Pathway in Streptozotocin-Induced Diabetes Mellitus in Wistar Rats.

Authors:  Maryam Arabloei Sani; Parichehreh Yaghmaei; Zahra Hajebrahimi; Nasim Hayati Roodbari
Journal:  J Obes       Date:  2022-04-26

Review 5.  Dietary antioxidative supplements and diabetic retinopathy; a systematic review.

Authors:  Ozra Tabatabaei-Malazy; Edris Ardeshirlarijani; Nazli Namazi; Shekoufeh Nikfar; Reza Baradar Jalili; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-08-30

Review 6.  Novel drugs and their targets in the potential treatment of diabetic retinopathy.

Authors:  Mohd Imtiaz Nawaz; Marwan Abouammoh; Haseeb A Khan; Abdullah S Alhomida; Mubarak F Alfaran; Mohammad Shamsul Ola
Journal:  Med Sci Monit       Date:  2013-04-26

Review 7.  Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?

Authors:  Siu Wai Choi; Cyrus K Ho
Journal:  Redox Rep       Date:  2017-05-17       Impact factor: 4.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.